Posts Tagged "drug plants"

F.D.A. Again Warns a Generic Maker About Conditions at Its Plants

Posted on Apr 19, 2010 in Uncategorized

By NATASHA SINGER   Jim Ross for The New York Times A worker at Apotex in Toronto. The Canadian company was said to have $879 million in United States sales last year. In the letter, posted on the Food and Drug Administration’s Web site late Wednesday, the agency cited lapses at Apotex, Canada’s biggest drug company, that included charred particles in a diabetes drug; contamination of an antihistamine, and drug cross-contamination that resulted from inadequate cleaning of manufacturing equipment. The letter also said the company had failed to notify regulators in a timely fashion about such...

Read More